Scholarly Index
Zhen Wang
Beijing Anzhen Hospital; 19,166 total citations; 851 total publications; best world rank #14
Beijing Anzhen Hospital
19,166Total citations
851Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 549 | CN 89 | 97.93 |
| Long-Term Effects of COVID-19 | Lifetime | 899 | CN 58 | 94.55 |
| Cardiac Fibrosis and Remodeling | Lifetime | 322 | CN 27 | 95.61 |
| Mercury impact and mitigation studies | Lifetime | 944 | CN 183 | 94.64 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 863 | CN 9 | 74.99 |
| Whipple's Disease and Interleukins | Lifetime | 951 | CN 72 | 49.71 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 14 | CN 3 | 96.94 |
| COVID-19 Clinical Research Studies | 2021-2025 | 598 | CN 51 | 97.36 |
| Signaling Pathways in Disease | 2021-2025 | 50 | CN 18 | 88.49 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 710 | CN 122 | 84.35 |
| Cancer Treatment and Pharmacology | 2021-2025 | 836 | CN 81 | 85.35 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 476 | CN 49 | 78.69 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 810 | CN 167 | 77.21 |
| Phagocytosis and Immune Regulation | 2021-2025 | 696 | CN 290 | 69.75 |
| Fatty Acid Research and Health | 2021-2025 | 872 | CN 171 | 68.92 |
| NF-κB Signaling Pathways | 2021-2025 | 433 | CN 171 | 52.38 |